SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-296984
Filing Date
2021-10-12
Accepted
2021-10-12 17:01:08
Documents
12
Period of Report
2021-10-11
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d418271d8k.htm   iXBRL 8-K 24253
  Complete submission text file 0001193125-21-296984.txt   150744

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA stsa-20211011.xsd EX-101.SCH 2895
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE stsa-20211011_lab.xml EX-101.LAB 18888
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE stsa-20211011_pre.xml EX-101.PRE 11862
5 EXTRACTED XBRL INSTANCE DOCUMENT d418271d8k_htm.xml XML 3471
Mailing Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080
Business Address 400 OYSTER POINT BOULEVARD SUITE 221 SOUTH SAN FRANCISCO CA 64080 415-505-0809
Satsuma Pharmaceuticals, Inc. (Filer) CIK: 0001692830 (see all company filings)

IRS No.: 813039831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39041 | Film No.: 211319211
SIC: 2834 Pharmaceutical Preparations